nodes	percent_of_prediction	percent_of_DWPC	metapath
Colestipol—Cholecystitis—Vandetanib—thyroid cancer	0.0458	0.0458	CcSEcCtD
Colestipol—Cholelithiasis—Vandetanib—thyroid cancer	0.0423	0.0423	CcSEcCtD
Colestipol—Cholecystitis—Sorafenib—thyroid cancer	0.0309	0.0309	CcSEcCtD
Colestipol—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.0191	0.0191	CcSEcCtD
Colestipol—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.0168	0.0168	CcSEcCtD
Colestipol—Dysphagia—Vandetanib—thyroid cancer	0.0165	0.0165	CcSEcCtD
Colestipol—Haematochezia—Epirubicin—thyroid cancer	0.0163	0.0163	CcSEcCtD
Colestipol—Haematochezia—Doxorubicin—thyroid cancer	0.0151	0.0151	CcSEcCtD
Colestipol—Hepatobiliary disease—Vandetanib—thyroid cancer	0.0139	0.0139	CcSEcCtD
Colestipol—Pain in extremity—Sorafenib—thyroid cancer	0.0129	0.0129	CcSEcCtD
Colestipol—Cardiac disorder—Vandetanib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Colestipol—Mediastinal disorder—Vandetanib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Colestipol—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.0116	0.0116	CcSEcCtD
Colestipol—Mental disorder—Vandetanib—thyroid cancer	0.0116	0.0116	CcSEcCtD
Colestipol—Malnutrition—Vandetanib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Colestipol—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Colestipol—Dysphagia—Sorafenib—thyroid cancer	0.0111	0.0111	CcSEcCtD
Colestipol—Muscle spasms—Vandetanib—thyroid cancer	0.0111	0.0111	CcSEcCtD
Colestipol—Abdominal discomfort—Sorafenib—thyroid cancer	0.0107	0.0107	CcSEcCtD
Colestipol—Chest pain—Vandetanib—thyroid cancer	0.00979	0.00979	CcSEcCtD
Colestipol—Arthralgia—Vandetanib—thyroid cancer	0.00979	0.00979	CcSEcCtD
Colestipol—Anxiety—Vandetanib—thyroid cancer	0.00976	0.00976	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00972	0.00972	CcSEcCtD
Colestipol—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00939	0.00939	CcSEcCtD
Colestipol—Nervous system disorder—Vandetanib—thyroid cancer	0.0092	0.0092	CcSEcCtD
Colestipol—Skin disorder—Vandetanib—thyroid cancer	0.00912	0.00912	CcSEcCtD
Colestipol—Connective tissue disorder—Sorafenib—thyroid cancer	0.00876	0.00876	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00855	0.00855	CcSEcCtD
Colestipol—Insomnia—Vandetanib—thyroid cancer	0.00849	0.00849	CcSEcCtD
Colestipol—Dyspnoea—Vandetanib—thyroid cancer	0.00837	0.00837	CcSEcCtD
Colestipol—Cardiac disorder—Sorafenib—thyroid cancer	0.00827	0.00827	CcSEcCtD
Colestipol—Dyspepsia—Vandetanib—thyroid cancer	0.00826	0.00826	CcSEcCtD
Colestipol—Decreased appetite—Vandetanib—thyroid cancer	0.00816	0.00816	CcSEcCtD
Colestipol—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0081	0.0081	CcSEcCtD
Colestipol—Fatigue—Vandetanib—thyroid cancer	0.00809	0.00809	CcSEcCtD
Colestipol—Mediastinal disorder—Sorafenib—thyroid cancer	0.00803	0.00803	CcSEcCtD
Colestipol—Constipation—Vandetanib—thyroid cancer	0.00803	0.00803	CcSEcCtD
Colestipol—Pain—Vandetanib—thyroid cancer	0.00803	0.00803	CcSEcCtD
Colestipol—Mental disorder—Sorafenib—thyroid cancer	0.00781	0.00781	CcSEcCtD
Colestipol—Malnutrition—Sorafenib—thyroid cancer	0.00776	0.00776	CcSEcCtD
Colestipol—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00767	0.00767	CcSEcCtD
Colestipol—Muscle spasms—Sorafenib—thyroid cancer	0.00746	0.00746	CcSEcCtD
Colestipol—Abdominal pain—Vandetanib—thyroid cancer	0.00742	0.00742	CcSEcCtD
Colestipol—Asthenia—Vandetanib—thyroid cancer	0.00673	0.00673	CcSEcCtD
Colestipol—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00664	0.00664	CcSEcCtD
Colestipol—Arthralgia—Sorafenib—thyroid cancer	0.0066	0.0066	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00656	0.00656	CcSEcCtD
Colestipol—Eructation—Epirubicin—thyroid cancer	0.00644	0.00644	CcSEcCtD
Colestipol—Diarrhoea—Vandetanib—thyroid cancer	0.00642	0.00642	CcSEcCtD
Colestipol—Nervous system disorder—Sorafenib—thyroid cancer	0.00621	0.00621	CcSEcCtD
Colestipol—Dizziness—Vandetanib—thyroid cancer	0.00621	0.00621	CcSEcCtD
Colestipol—Skin disorder—Sorafenib—thyroid cancer	0.00615	0.00615	CcSEcCtD
Colestipol—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00614	0.00614	CcSEcCtD
Colestipol—Anorexia—Sorafenib—thyroid cancer	0.00603	0.00603	CcSEcCtD
Colestipol—Vomiting—Vandetanib—thyroid cancer	0.00597	0.00597	CcSEcCtD
Colestipol—Eructation—Doxorubicin—thyroid cancer	0.00596	0.00596	CcSEcCtD
Colestipol—Rash—Vandetanib—thyroid cancer	0.00592	0.00592	CcSEcCtD
Colestipol—Dermatitis—Vandetanib—thyroid cancer	0.00591	0.00591	CcSEcCtD
Colestipol—Headache—Vandetanib—thyroid cancer	0.00588	0.00588	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00577	0.00577	CcSEcCtD
Colestipol—Dyspnoea—Sorafenib—thyroid cancer	0.00564	0.00564	CcSEcCtD
Colestipol—Nausea—Vandetanib—thyroid cancer	0.00557	0.00557	CcSEcCtD
Colestipol—Dyspepsia—Sorafenib—thyroid cancer	0.00557	0.00557	CcSEcCtD
Colestipol—Decreased appetite—Sorafenib—thyroid cancer	0.0055	0.0055	CcSEcCtD
Colestipol—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00547	0.00547	CcSEcCtD
Colestipol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00547	0.00547	CcSEcCtD
Colestipol—Fatigue—Sorafenib—thyroid cancer	0.00546	0.00546	CcSEcCtD
Colestipol—Pain—Sorafenib—thyroid cancer	0.00541	0.00541	CcSEcCtD
Colestipol—Constipation—Sorafenib—thyroid cancer	0.00541	0.00541	CcSEcCtD
Colestipol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00518	0.00518	CcSEcCtD
Colestipol—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00506	0.00506	CcSEcCtD
Colestipol—Urticaria—Sorafenib—thyroid cancer	0.00503	0.00503	CcSEcCtD
Colestipol—Abdominal pain—Sorafenib—thyroid cancer	0.005	0.005	CcSEcCtD
Colestipol—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00476	0.00476	CcSEcCtD
Colestipol—Pain in extremity—Epirubicin—thyroid cancer	0.00476	0.00476	CcSEcCtD
Colestipol—Migraine—Epirubicin—thyroid cancer	0.00469	0.00469	CcSEcCtD
Colestipol—Hypersensitivity—Sorafenib—thyroid cancer	0.00466	0.00466	CcSEcCtD
Colestipol—Asthenia—Sorafenib—thyroid cancer	0.00454	0.00454	CcSEcCtD
Colestipol—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.0044	0.0044	CcSEcCtD
Colestipol—Pain in extremity—Doxorubicin—thyroid cancer	0.0044	0.0044	CcSEcCtD
Colestipol—Migraine—Doxorubicin—thyroid cancer	0.00434	0.00434	CcSEcCtD
Colestipol—Diarrhoea—Sorafenib—thyroid cancer	0.00433	0.00433	CcSEcCtD
Colestipol—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00429	0.00429	CcSEcCtD
Colestipol—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.0042	0.0042	CcSEcCtD
Colestipol—Dizziness—Sorafenib—thyroid cancer	0.00419	0.00419	CcSEcCtD
Colestipol—Abdominal distension—Epirubicin—thyroid cancer	0.00414	0.00414	CcSEcCtD
Colestipol—Dysphagia—Epirubicin—thyroid cancer	0.00411	0.00411	CcSEcCtD
Colestipol—Vomiting—Sorafenib—thyroid cancer	0.00403	0.00403	CcSEcCtD
Colestipol—Angina pectoris—Epirubicin—thyroid cancer	0.00401	0.00401	CcSEcCtD
Colestipol—Rash—Sorafenib—thyroid cancer	0.00399	0.00399	CcSEcCtD
Colestipol—Dermatitis—Sorafenib—thyroid cancer	0.00399	0.00399	CcSEcCtD
Colestipol—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00397	0.00397	CcSEcCtD
Colestipol—Headache—Sorafenib—thyroid cancer	0.00397	0.00397	CcSEcCtD
Colestipol—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00388	0.00388	CcSEcCtD
Colestipol—Abdominal distension—Doxorubicin—thyroid cancer	0.00383	0.00383	CcSEcCtD
Colestipol—Dysphagia—Doxorubicin—thyroid cancer	0.00381	0.00381	CcSEcCtD
Colestipol—Nausea—Sorafenib—thyroid cancer	0.00376	0.00376	CcSEcCtD
Colestipol—Angina pectoris—Doxorubicin—thyroid cancer	0.00371	0.00371	CcSEcCtD
Colestipol—Drowsiness—Epirubicin—thyroid cancer	0.00367	0.00367	CcSEcCtD
Colestipol—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00347	0.00347	CcSEcCtD
Colestipol—Drowsiness—Doxorubicin—thyroid cancer	0.00339	0.00339	CcSEcCtD
Colestipol—Oedema peripheral—Epirubicin—thyroid cancer	0.00324	0.00324	CcSEcCtD
Colestipol—Connective tissue disorder—Epirubicin—thyroid cancer	0.00324	0.00324	CcSEcCtD
Colestipol—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00321	0.00321	CcSEcCtD
Colestipol—Cardiac disorder—Epirubicin—thyroid cancer	0.00306	0.00306	CcSEcCtD
Colestipol—Oedema peripheral—Doxorubicin—thyroid cancer	0.003	0.003	CcSEcCtD
Colestipol—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00299	0.00299	CcSEcCtD
Colestipol—Mediastinal disorder—Epirubicin—thyroid cancer	0.00297	0.00297	CcSEcCtD
Colestipol—Mental disorder—Epirubicin—thyroid cancer	0.00289	0.00289	CcSEcCtD
Colestipol—Malnutrition—Epirubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Colestipol—Cardiac disorder—Doxorubicin—thyroid cancer	0.00283	0.00283	CcSEcCtD
Colestipol—Flatulence—Epirubicin—thyroid cancer	0.00282	0.00282	CcSEcCtD
Colestipol—Back pain—Epirubicin—thyroid cancer	0.00277	0.00277	CcSEcCtD
Colestipol—Muscle spasms—Epirubicin—thyroid cancer	0.00276	0.00276	CcSEcCtD
Colestipol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00275	0.00275	CcSEcCtD
Colestipol—Mental disorder—Doxorubicin—thyroid cancer	0.00267	0.00267	CcSEcCtD
Colestipol—Malnutrition—Doxorubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Colestipol—Flatulence—Doxorubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Colestipol—Vertigo—Epirubicin—thyroid cancer	0.00258	0.00258	CcSEcCtD
Colestipol—Back pain—Doxorubicin—thyroid cancer	0.00257	0.00257	CcSEcCtD
Colestipol—Muscle spasms—Doxorubicin—thyroid cancer	0.00255	0.00255	CcSEcCtD
Colestipol—Arthralgia—Epirubicin—thyroid cancer	0.00244	0.00244	CcSEcCtD
Colestipol—Chest pain—Epirubicin—thyroid cancer	0.00244	0.00244	CcSEcCtD
Colestipol—Anxiety—Epirubicin—thyroid cancer	0.00243	0.00243	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Colestipol—Vertigo—Doxorubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Colestipol—Nervous system disorder—Epirubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Colestipol—Tachycardia—Epirubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Colestipol—Skin disorder—Epirubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Colestipol—Arthralgia—Doxorubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Colestipol—Chest pain—Doxorubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Colestipol—Anxiety—Doxorubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Colestipol—Anorexia—Epirubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00213	0.00213	CcSEcCtD
Colestipol—Nervous system disorder—Doxorubicin—thyroid cancer	0.00212	0.00212	CcSEcCtD
Colestipol—Insomnia—Epirubicin—thyroid cancer	0.00212	0.00212	CcSEcCtD
Colestipol—Tachycardia—Doxorubicin—thyroid cancer	0.00211	0.00211	CcSEcCtD
Colestipol—Skin disorder—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Colestipol—Dyspnoea—Epirubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Colestipol—Somnolence—Epirubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Colestipol—Anorexia—Doxorubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Colestipol—Dyspepsia—Epirubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Colestipol—Decreased appetite—Epirubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Colestipol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Colestipol—Fatigue—Epirubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Colestipol—Pain—Epirubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Colestipol—Constipation—Epirubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00197	0.00197	CcSEcCtD
Colestipol—Insomnia—Doxorubicin—thyroid cancer	0.00196	0.00196	CcSEcCtD
Colestipol—Dyspnoea—Doxorubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Colestipol—Somnolence—Doxorubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Colestipol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Colestipol—Dyspepsia—Doxorubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Colestipol—Decreased appetite—Doxorubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Colestipol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Colestipol—Fatigue—Doxorubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Colestipol—Urticaria—Epirubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Colestipol—Pain—Doxorubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Colestipol—Constipation—Doxorubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Colestipol—Abdominal pain—Epirubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Colestipol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Colestipol—Hypersensitivity—Epirubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Colestipol—Urticaria—Doxorubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Colestipol—Abdominal pain—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Colestipol—Asthenia—Epirubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Colestipol—Diarrhoea—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Colestipol—Hypersensitivity—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Colestipol—Asthenia—Doxorubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Colestipol—Dizziness—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Colestipol—Vomiting—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Colestipol—Diarrhoea—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Colestipol—Rash—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Colestipol—Dermatitis—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Colestipol—Headache—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Colestipol—Dizziness—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Colestipol—Nausea—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Colestipol—Vomiting—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Colestipol—Rash—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Colestipol—Dermatitis—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Colestipol—Headache—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Colestipol—Nausea—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
